ABBV

ABBVIE INC

5 catalysts on file

ABBV

ABBVIE INC

Approval Confirmed

Skyrizi

352d ago Sep 3, 2025

openFDA verified 2mo ago

ABBV

AbbVie Inc.

Catalyst AI-extracted

moderately to severely active Crohn's disease (CD)

T-minus 132 days ~ Dec 31, 2026

SEC 8-K verified 2mo ago

ABBV

AbbVie

Phase 2 Estimated

Lutikizumab

Atopic Dermatitis

T-minus 283 days ~ May 31, 2027

ClinicalTrials.gov verified 2mo ago

ABBV

AbbVie Inc.

Approval AI-extracted

previously untreated adult chronic lymphocytic leukemia (CLL)

Date TBD Date TBD

SEC 8-K verified 2mo ago

ABBV

AbbVie Inc.

CRL AI-extracted

Undisclosed program

Date TBD Date TBD

SEC 8-K verified 2mo ago